03:45 PM EST - Cipher Pharmaceuticals Inc. : reported a net loss of $500,000 or $0.02 per share for the first quarter, compared to a loss of $800,000 or $0.03 per share in the prior-year quarter. Total revenue increased 52% to $900,000 from $600,000 in the year-ago quarter, driven by growth of Lipofen prescriptions. Cipher Pharmaceuticals Inc.
shares T.DND are trading up $0.20 at $1.45.
